BioClever

Barcelona, Spain Founded: 2005 • Age: 21 yrs Acquired By Henko Partners
Provider of full-service clinical research support

About BioClever

BioClever is a Healthcare company based in Barcelona (Spain) founded in 2005 by Jordi Cantoni Ayguaviva and Mireia Bonet Vidal, and was acquired by Henko Partners in July 2022. Provider of full-service clinical research support. BioClever offers products and services including Clinical Trials, Data Management, Project Management, and Pharmacovigilance. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service.

Company details

BioClever was established in 2005 in Barcelona, Spain, within the clinical research sector. Operations encompass the conduction of trials from phase I to IV in multiple therapeutic areas. Services provided include project management, monitoring, biostatistics, medical writing, and quality assurance. Manufacturing facilities are certified under ISO 9001:2015 standards.

  • Headquarters Barcelona, Spain
  • Founders Jordi Cantoni Ayguaviva, Mireia Bonet Vidal
  • Stage Acquired
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website bioclever.com
  • Social LinkedIn X Facebook
  • Acquired by Henko Partners (Jul 2022)
Key Metrics

Products & Services of BioClever

BioClever offers a comprehensive portfolio of products and services, including Clinical Trials, Data Management, Project Management, and Pharmacovigilance.

Clinical Trials
Research Services

Conducting trials for drug and device testing

Data Management
Data Services

Handling clinical data for analysis and standardization

Project Management
Operational Services

Managing clinical study design and execution

Pharmacovigilance
Safety Services

Monitoring drug safety during trials

Investors in BioClever

BioClever has secured backing from 1 investor. Prominent investors backing the company include Henko Partners.

All
InvestorDescriptionFounded YearDomainLocation
Private equity firm focused on small and medium size companies
2021henkopartners.comMadrid, Spain
Premium access

Investor details for BioClever

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of BioClever

2 people are tracked at BioClever (2 in leadership).

NameRoleGroup
Jordi Cantoni Ayguaviva
Co-FounderLeadership
Mireia Bonet Vidal
Co-FounderLeadership
Premium access

Complete people profiles for BioClever

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of BioClever

2 dated milestones of BioClever across 17 years, from founding to its latest funding, stage changes and deals.

  1. Founded BioClever is founded.
  2. Exit Acquired by Henko Partners.

Web traffic of BioClever

The website of BioClever (bioclever.com) receives about 1.5K visits a month and ranks #8,176,899 among all websites worldwide, #7,281 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    1.5K

    ▼ 1.7% vs previous month

  • Global rank
    #8,176,899

    among all websites

  • Category rank
    #7,281

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with BioClever. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
antidote.me
100%
99.4K#315,124View details
istartsurf.com
istartsurf.com
63%
–
twitter.com
63%
View details
wordworks.es
wordworks.es
44%
#12,698,596–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Bioclever

Premium access

Complete news archive for BioClever

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BioClever

BioClever was founded in 2005.

BioClever is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.

BioClever was established in 2005 in Barcelona, Spain, within the clinical research sector. Operations encompass the conduction of trials from phase I to IV in multiple therapeutic areas. Services provided include project management, monitoring, biostatistics, medical writing, and quality assurance. Manufacturing facilities are certified under ISO 9001:2015 standards.

BioClever offers Clinical Trials, Data Management, Project Management, and Pharmacovigilance.

BioClever has 1 investor. Key investors include Henko Partners.

Yes. BioClever was acquired by Henko Partners in July 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available